ResearchSource: The Journal of Clinical Endocrinology & Metabolism

Experts debate TSH threshold for levothyroxine use in pregnancy

A published debate examines differing views on when to initiate levothyroxine for pregnant women with TSH concentrations between 2.5 and 10 mIU/L, following recent guidelines that raised the treatment threshold to TSH 4.0 mIU/L or higher with normal thyroxine, and that recommend against treatment between 2.5 and 4.0 mIU/L. One clinician argues individualized treatment may still be reasonable for select women with TSH 2.5-4.0 mIU/L and supports considering treatment for TSH 4.0-10.0 mIU/L, citing biological heterogeneity and evidence gaps, while the other argues against routine treatment in this range, citing uncertain benefit and risk of overtreatment.

Most relevant for: Clinicians managing pregnant women with mild thyroid dysfunction, particularly subclinical hypothyroidism identified in the first trimester.

Read the original at The Journal of Clinical Endocrinology & Metabolism

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.

Specialties

More endocrinology updates

Get updates for your specialty